๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA ยท Real-Time Price ยท USD
25.80
-0.40 (-1.53%)
Nov 18, 2026, 12:56 PM EST - Market open

Vera Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-427.53-315.47-167.17-102.01-90.9-34.4
Net Income
-415.31-299.62-152.15-95.99-89.06-32.61
Earnings Per Share
-5.91-4.66-2.75-2.25-3.35-2.43
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
384.04714.59640.85160.72114.6579.67
Total Debt
76.7977.3154.6453.7131.294.92
Net Cash (Debt)
307.25637.28586.21107.0183.3774.75
Net Cash Growth
-26.88%8.71%447.82%28.36%11.53%39.10%
Net Cash Per Share
4.379.9210.602.513.145.56

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-375.92-241.1-134.68-92.18-67.6-23.71
Capital Expenditures
-0.13-0.63-0.97-0.06-0.06-
Free Cash Flow
-376.05-241.73-135.65-92.24-67.66-23.71
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.